Zegalogue .6 mg/.6mL (Dasiglucagon INJECTION, SOLUTION) .6 mg/.6mL

Zegalogue 0.6 mg/0.6mL is a glucagon injection used for severe hypoglycemia. This solution is designed for subcutaneous administration and is manufactured by Novo Nordisk in the USA.

Strength

.6 mg/.6mL

Pack Size

1 CONTAINER in 1 PACKAGE (0169-1913-01) / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLA

Manufacturer / TM Owner

Novo Nordisk

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Zegalogue 0.6 mg/0.6mL is primarily used for the treatment of severe hypoglycemia, a condition characterized by very low blood sugar levels. This medication works by raising blood sugar levels quickly. It is often used in emergency situations where a person is unable to consume food or drink to raise their blood sugar levels on their own. The injection is designed for subcutaneous use, making it easy to administer in critical moments.

Side Effects

Common effects of Zegalogue 0.6 mg/0.6mL may include temporary increases in heart rate and blood pressure. Some individuals might experience nausea or vomiting shortly after administration. These effects are generally short-lived and are part of the body's response to the rapid increase in blood sugar levels.

Precautions & Warnings

Zegalogue 0.6 mg/0.6mL should be handled with care and stored as directed to maintain its effectiveness. It is important to follow the instructions provided by a healthcare professional regarding the administration and storage of this medication. Always ensure that the solution is clear and free from particles before use.

Avoid Interactions

Zegalogue 0.6 mg/0.6mL may interact with certain medications, including those that affect blood sugar levels. It is advisable to consult with a healthcare professional before using this medication if you are taking other drugs, especially those that influence glucose metabolism. Alcohol and other substances that affect blood sugar should be considered when using this injection.

Frequently Asked Questions

Zegalogue 0.6 mg/0.6mL is used for the treatment of severe hypoglycemia, helping to quickly raise blood sugar levels in emergency situations.

Zegalogue 0.6 mg/0.6mL is designed for subcutaneous administration. Follow the instructions provided by a healthcare professional for proper use.

Common effects may include temporary increases in heart rate and blood pressure, as well as nausea or vomiting shortly after administration.

It is advisable to consult with a healthcare professional before using Zegalogue 0.6 mg/0.6mL with other medications, especially those that affect blood sugar levels.

Zegalogue 0.6 mg/0.6mL should be stored as directed to maintain its effectiveness. Always ensure the solution is clear and free from particles before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.